Full Text View
Tabular View
Study Results
Related Studies
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma (REGAL)
This study is ongoing, but not recruiting participants.
Study NCT00777153   Information provided by AstraZeneca

First Received on October 20, 2008.   Last Updated on July 14, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial